The United States federal government has committed $481 million in funding to Cue Health, the makers of a rapid COVID-19 test that was used in the NBA bubble. The investment is to increase production of the rapid test from thousands of daily tests to 100,000 daily tests by March, 2021.
The Cue Health Rapid COVID-19 test shows results in 25 minutes. It was used in the NBA bubble to conduct quick testing for players, coaches and other quarantined individuals. The technology proved successful as the bubble had zero positive COVID-19 readings during the 3 months in lockdown.
Tests contain a nasal swab that is then placed into a cartridge which is approximately the size of a Apple AirPod case. After 25 minutes, results are given through a smartphone app and are as accurate as current testing means.
Through this investment the US Government is purchasing 6 million single use tests and 30,000 associated instruments.
Rapid COVID-19 tests are instrumental in helping safeguard against COVID-19. These rapid tests allow individuals to have quick turnaround of diagnosis which can then let them isolate from the general population when needed. This works for both symptomatic and asymptomatic individuals.
While we wait for a COVID-19 vaccine, rapid testing remains a key tool to slow the spread of the Coronavirus.